인쇄하기
취소

Is GSK preparing to launch migraine drugs? The company refused it

Published: 2016-09-28 16:09:22
Updated: 2016-09-28 16:09:22

While there was a rumor about transfer of antihypertensive ‘Pritor’ license not long ago, people concerned to the industry made an anticipation that GSK soon will launch a pain killer, Panadol or Excedrin. The company, however, responded this has never been discussed.

According to the industry on the 25th, a joint OTC drug company between GSK and Novartis, GSK Consumer Healthcare,’ was expecte...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.